The problem here is that by “approving” the drug, the FDA implies that it truly works. People will take it expecting improvement, but their time will be wasted

The problem here is that by “approving” the drug, the FDA implies that it truly works. People will take it expecting improvement, but their time will be wasted and their hopes dashed. The approval process itself will lose credibility, and that will hurt everyone. By being devastating and long lasting, Alzheimer’s is not exceptional, compared to say cancer or even CVD. This decision really changes the perception of what the FDA is there for, if not to ensure efficacy and safety, then what?